Figure 2.
Generation and characterization of endothelial-specific YY1 deficient mice for the tumor angiogenesis. (A) Schematic diagram for the endothelial cell specific deletion of YY1 in mice (Ve-Cad-CreERT2; YY1flox/flox , YY1iΔEC ) and the strategy of the tumor angiogenesis study. The tumor was induced by melanoma B16-F10 cells (5 × 106 cells per mouse) with subcutaneously transplanted into 8-week-old WT or YY1i∆EC mice. (B) PCR analysis for the genotyping of Ve-Cad-CreERT2; YY1flox/flox mice (YY1iΔEC) and YY1flox/flox (WT) mice. (C) Immunofluorescence image of endothelial cell marker VE-Cadherin in lung endothelial cells isolated from YY1iΔEC mice. Nuclei were labeled by DAPI (blue) (Left panel) and Western blot analysis of endothelial YY1 expression in mouse lung endothelial cells isolated from WT and YY1iΔEC mice (n = 3) (Right panel). (D) Dual immunostaining analysis of YY1 (red) and endothelial cell marker CD31 (green) in melanoma tumor tissues isolated from WT and YY1iΔEC mice, (n = 7). Scale bars: 20 μm.